photo of

Details

Role Group Leader/DirectorAllergy Translation
Professor Mimi Tang is an immunologist allergist with an established international profile in the field of allergic disorders - she is considered a leading expert in food oral immunotherapy. She is Head of the Allergy Immunology Research Group and Director of the Allergy Translation Centre at Murdoch Children’s Research Institute, Professorial Fellow at the University of Melbourne Department of Paediatrics and Consultant Immunologist Allergist at Melbourne's Royal Children’s Hospital. Professor Tang has more than 25 years of experience in the investigation of basic immunological mechanisms underlying allergic disease pathogenesis and more than 15 years of clinical trials experience.

Professor Tang also collaborates on a number of longitudinal cohort studies including the Barwon Infant Study, HealthNuts and SchoolNuts and on the VITALITY clinical trial, and is a key leader within the NHMRC-funded CFAR CRE (Centre for Food and Allergy Research - a collaboration of experts in children’s food allergy and food-related immune disorders.

CFAR uses the latest approaches in epidemiology, immunology, paediatrics, nutrition, gastroenterology and biostatistics to investigate factors that cause, prevent and improve food allergies and aims to eradicate food allergy through improved prevention and cure, supported by evidence generated by a collaborative network of research; additional aim is to improve management of food allergy through public health policy and clinical pathways.
Professor Mimi Tang is an immunologist allergist with an established international profile in the field of allergic disorders - she is considered a leading expert in food oral immunotherapy. She is Head of the Allergy Immunology Research Group and...
Professor Mimi Tang is an immunologist allergist with an established international profile in the field of allergic disorders - she is considered a leading expert in food oral immunotherapy. She is Head of the Allergy Immunology Research Group and Director of the Allergy Translation Centre at Murdoch Children’s Research Institute, Professorial Fellow at the University of Melbourne Department of Paediatrics and Consultant Immunologist Allergist at Melbourne's Royal Children’s Hospital. Professor Tang has more than 25 years of experience in the investigation of basic immunological mechanisms underlying allergic disease pathogenesis and more than 15 years of clinical trials experience.

Professor Tang also collaborates on a number of longitudinal cohort studies including the Barwon Infant Study, HealthNuts and SchoolNuts and on the VITALITY clinical trial, and is a key leader within the NHMRC-funded CFAR CRE (Centre for Food and Allergy Research - a collaboration of experts in children’s food allergy and food-related immune disorders.

CFAR uses the latest approaches in epidemiology, immunology, paediatrics, nutrition, gastroenterology and biostatistics to investigate factors that cause, prevent and improve food allergies and aims to eradicate food allergy through improved prevention and cure, supported by evidence generated by a collaborative network of research; additional aim is to improve management of food allergy through public health policy and clinical pathways.

Top Publications

  • Tang, MLK, Mullins, RJ. Food allergy: is prevalence increasing?. Intern Med J 47(3) : 256 -261 2017
    view publication
  • Dhanapala, P, Withanage-Dona, D, Tang, MLK, Doran, T, Suphioglu, C. Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges.. Nutrients 9(2) : 2017
    view publication
  • Hsiao, K-C, Ponsonby, A-L, Axelrad, C, Pitkin, S, Tang, MLK. Long Term Effects of a Probiotic and Peanut Oral Immunotherapy (PPOIT) Treatment on Peanut Allergic Children. Journal of Allergy and Clinical Immunology 139(2) : ab136 2017
    view publication
  • McCloskey, K, Vuillermin, P, Carlin, JB, Cheung, M, Skilton, MR, Tang, ML, Allen, K, Gilbert, GL, Ranganathan, S, Collier, F, et al. Perinatal microbial exposure may influence aortic intima-media thickness in early infancy.. Int J Epidemiol 46(1) : 209 -218 2017
    view publication
  • Sly, PD, Varghese, J, Noor, F, Tang, MLK, Laing, I, Oo, S, Prastanti, F, LeSouef, PN, Holt, PG. Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect.. J Allergy Clin Immunol 139(2) : 703 -705.e4 2017
    view publication